FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
Tomorrow is the first day of fall; kick off cozy season with some tasty fall produce (it’s good for you!). And now, here’s ...
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
A pill Novo acquired produced modest weight loss but raised safety questions. Elsewhere, Sanofi detailed the silver lining it found in a recent study and a heart drug developer’s shares surged.
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
The FDA authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The AstraZeneca PLC ADR AZN slumped 0.66% to $78.38 Friday, on what proved to be an all-around mixed trading session for the ...
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback